Predictivity of the clock drawing test in the acute phase of cerebrovascular diseases on cognitive decline at a 6-month neuropsychological evaluation.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 29 10 2021
accepted: 03 12 2021
pubmed: 11 1 2022
medline: 24 2 2022
entrez: 10 1 2022
Statut: ppublish

Résumé

We showed that the Clock Drawing Test (CDT) performed during the acute phase of cerebrovascular diseases predicted worsening of cognitive function defined based on a clinical judgement at a 3-month follow-up. The aim of this study was to verify the predictivity of the CDT on the worsening of cognitive status assessed with an extensive neuropsychological evaluation 6 months after the acute event. Patients with a stroke or transient ischemic attack underwent a baseline clinical, neuroimaging, and neuropsychological assessment, including the CDT. Premorbid cognitive status was evaluated by means of the Clinical Dementia Rating scale. Between 6 and 7 months after the acute event, all patients underwent a neuropsychological evaluation that included tests for executive function, attention, language, memory, and visuospatial abilities. Fifty patients (29 males; mean age 72.2 years) were enrolled: 28 (56%) had no premorbid cognitive impairment, 15 (30%) had premorbid mild cognitive impairment (MCI), and 4 (8%) had premorbid dementia; for 3 patients, evaluation of premorbid status was not available. At follow-up, 11 (22%) had no cognitive impairment, 28 (56%) were diagnosed with MCI, and 11 (22%) dementia. In patients who were non-demented before the event, on regression analysis, the score obtained at CDT was predictive of decline of cognitive status at the 6-month follow-up (OR 1.65; 95% CI 1.08-2.52). Our study confirms that administering the CDT during the acute phase of cerebrovascular diseases is informative with regard to the worsening of cognitive function after 6 months.

Identifiants

pubmed: 35001189
doi: 10.1007/s10072-021-05809-8
pii: 10.1007/s10072-021-05809-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2073-2076

Informations de copyright

© 2021. Fondazione Società Italiana di Neurologia.

Références

Cova I, Mele F, Zerini F, Maggiore L, Cucumo V, Brambilla M, Rosa S, Bertora P, Salvadori E, Pomati S, Pantoni L (2020) Neuropsychological screening in the acute phase of cerebrovascular diseases. Acta Neurol Scand 142(4):377–384. https://doi.org/10.1111/ane.13319
doi: 10.1111/ane.13319 pubmed: 32687600
Salvi F, Miller MD, Grilli A et al (2008) A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc 56(10):1926–1931. https://doi.org/10.1111/j.1532-5415.2008.01935.x
doi: 10.1111/j.1532-5415.2008.01935.x pubmed: 18811613
Wahlund LO, Barkhof F, Fazekas F et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318–1322. https://doi.org/10.1161/01.str.32.6.1318
doi: 10.1161/01.str.32.6.1318 pubmed: 11387493
Pasquier F, Leys D, Weerts JGE, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36(5):268–272. https://doi.org/10.1159/000117270
doi: 10.1159/000117270 pubmed: 8864706
Knopman DS, Kramer JH, Boeve BF et al (2008) Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131(Pt 11):2957–2968. https://doi.org/10.1093/brain/awn234
doi: 10.1093/brain/awn234 pubmed: 18829698 pmcid: 2725027
Julayanont P, Tangwongchai S, Hemrungrojn S et al (2015) The Montreal Cognitive Assessment-Basic: a screening tool for mild cognitive impairment in illiterate and low-educated elderly adults. J Am Geriatr Soc 63(12):2550–2554. https://doi.org/10.1111/jgs.13820
doi: 10.1111/jgs.13820 pubmed: 26648041
Caffarra P, Gardini S, Zonato F et al (2011) Italian norms for the Freedman version of the Clock Drawing Test. J Clin Exp Neuropsychol 33(9):982–988. https://doi.org/10.1080/13803395.2011.589373
doi: 10.1080/13803395.2011.589373 pubmed: 22082081
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37(9):2220–2241. https://doi.org/10.1161/01.STR.0000237236.88823.47
doi: 10.1161/01.STR.0000237236.88823.47 pubmed: 16917086
Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2018 Mar 14 3 280 92 https://doi.org/10.1016/j.jalz.2017.09.007
Quinn TJ, Richard E, Teuschl Y, Gattringer T, Hafdi M, O'Brien JT, Merriman N, Gillebert C, Huyglier H, Verdelho A, Schmidt R, Ghaziani E, Forchammer H, Pendlebury ST, Bruffaerts R, Mijajlovic M, Drozdowska BA, Ball E, Markus HS. European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. Eur Stroke J. 2021 Sep;6(3):I-XXXVIII. https://doi.org/10.1177/23969873211042192
Champod AS, Gubitz GJ, Phillips SJ et al (2019) Clock Drawing Test in acute stroke and its relationship with long-term functional and cognitive outcomes. Clin Neuropsychol 33(5):817–830. https://doi.org/10.1080/13854046.2018.1494307
doi: 10.1080/13854046.2018.1494307 pubmed: 29985104

Auteurs

Francesco Mele (F)

Neurology Unit, Luigi Sacco University Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy.

Ilaria Cova (I)

Neurology Unit, Luigi Sacco University Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy.

Federico Benzi (F)

Stroke and Dementia Lab, "Luigi Sacco" Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Federica Zerini (F)

Stroke and Dementia Lab, "Luigi Sacco" Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Valentina Cucumo (V)

Neurology Unit, Luigi Sacco University Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy.

Michela Brambilla (M)

Neurology Unit, Luigi Sacco University Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy.

Pierluigi Bertora (P)

Stroke and Dementia Lab, "Luigi Sacco" Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Emilia Salvadori (E)

NEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.

Simone Pomati (S)

Neurology Unit, Luigi Sacco University Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy.

Leonardo Pantoni (L)

Neurology Unit, Luigi Sacco University Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy. leonardo.pantoni@unimi.it.
Stroke and Dementia Lab, "Luigi Sacco" Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy. leonardo.pantoni@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH